Page last updated: 2024-10-27

fluconazole and Albers-Schoenberg Disease

fluconazole has been researched along with Albers-Schoenberg Disease in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Osteopetrosis is a rare inherited disease caused by osteoclast failure, resulting in increasing bone density in humans."5.91Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients. ( Alaiya, A; Alkhayal, Z; Gaafar, A; Shinwari, Z, 2023)
"Osteopetrosis is a rare inherited disease caused by osteoclast failure, resulting in increasing bone density in humans."1.91Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients. ( Alaiya, A; Alkhayal, Z; Gaafar, A; Shinwari, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alkhayal, Z1
Shinwari, Z1
Gaafar, A1
Alaiya, A1

Other Studies

1 other study available for fluconazole and Albers-Schoenberg Disease

ArticleYear
Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients.
    International journal of molecular sciences, 2023, Sep-08, Volume: 24, Issue:18

    Topics: Azoles; Dental Pulp; Fluconazole; Humans; Mesenchymal Stem Cells; Metabolic Networks and Pathways; O

2023